首页>
外国专利>
USE OF INDOLOQUINOXALINE DERIVATIVES FOR PREPARING A DRUG FOR TREATMENT OF MS
USE OF INDOLOQUINOXALINE DERIVATIVES FOR PREPARING A DRUG FOR TREATMENT OF MS
展开▼
机译:使用吲哚喹啉衍生物制备用于MS治疗的药物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the use of a substituted indole quinoxaline derivative of formula (I) and its addition products with physiologically acceptable acid halide adducts, preferably iodides, iodine monochlorides or iodine monobromides, for the preparation of a medicament for the treatment of multiple sclerosis. or a plurality of, preferably 1-4, identical or different substituents at the 1-4 and / or 7-10 positions selected from the group consisting of halogen, preferably bromine, alkyl and / or alkoxy having up to 4 carbon atoms, trifluoromethyl, trichloromethyl or, when R1 is attached to one of positions 7 to 10, it may also represent a hydroxy group; X is - (CH 2) n -R 2, wherein R 2 is a basic nitrogen-containing group such as -NH 2, -NHR 4, or -NR 5 R 6 where R 4, R 5 and R 6 are independently lower alkyl or cycloalkyl; An integer from 1 to 4; R3 is hydrogen, alkyl or cycloalkyl having up to 4 carbon atoms. HE
展开▼
机译:本发明涉及式(I)的取代的吲哚喹喔啉衍生物及其加成产物与生理上可接受的酰卤加合物,优选碘化物,一氯化碘或一溴化碘在制备用于治疗多发性硬化症的药物中的用途。 。或选自1-4个和/或7-10个位置的多个或优选1-4个相同或不同的取代基,所述取代基选自卤素,优选溴,烷基和/或具有至多4个碳原子的烷氧基,三氟甲基,三氯甲基,或当R1连接在7至10位之一时,它也可以代表羟基; X为-(CH 2)n -R 2,其中R 2为碱性含氮基团,例如-NH 2,-NHR 4或-NR 5 R 6,其中R 4,R 5和R 6独立地较低。烷基或环烷基; 1到4之间的整数; R 3为氢,烷基或具有至多4个碳原子的环烷基。他
展开▼